NCT06280261

Brief Summary

Objective: To assess the stress levels and life hardships of phenylketonuria patients and their parents.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
156

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 27, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

February 10, 2024

Completed
18 days until next milestone

First Posted

Study publicly available on registry

February 28, 2024

Completed
Last Updated

February 28, 2024

Status Verified

February 1, 2024

Enrollment Period

3 months

First QC Date

February 10, 2024

Last Update Submit

February 19, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Rosenberg Self-Esteem Scale

    Rosenberg Self-Esteem Scale was developed by Morris Rosenberg in 1960. It evaluates self-esteem and consists of 10 items in total. In the Likert-type scale, which includes positively and negatively charged items, 0-1 points are considered as high self-esteem, 2-4 points as medium self-esteem, and 5-6 points as low self-esteem.

    12 minutes

  • Stait trait anxiety inventory

    State-Trait Anxiety Inventory is an inventory that measures state and trait anxiety levels of children. It has been developed by Spielberges et. al in 1983. It consists of two questionnaires with a total of 40 questions, 20 that assesses the anxiety level stately, that is, how the child feels at that moment, and 20 that assesses how he feels constantly, that is, in general. The scale is in 3-point Likert type and is evaluated with 1-3 points according to symptom severityThe lowest score that can be obtained from the scales is 20, and the highest score is 60, higher scores indicate higher anxiety.

    45 minutes

  • Strenghts and difficulties questionnaire

    Strengths and Difficulties Questionnaire was developed by Goodman in 1997 to assess children's social, emotional and behavioral difficulties. There is a parent form for ages 4-17 and a child form for ages 11-17. It consists of 25 questions in total

    30 minutes

  • Zarit burden scale

    Zarit Burden Scale was developed by Zarit et al. in 1980. It is a 5-point Likert-type scale consisting of 22 questions that aims to measure the distress experienced by caregivers. Answers are scored between 0-4. A minimum of 0 and a maximum of 88 points can be obtained from the scale. The high score indicates the height of the distress experienced.

    25 minutes

  • Parenting stress index

    Parenting Stress Index aims to measure the stress experienced by parents in their relationships with their children. It is a 4-point Likert-type scale consisting of 16 questions in total. A minimum of 16 and a maximum of 64 points can be obtained from the scale. A high score from the scale indicates that parental stress is high.

    20 minutes

Interventions

Eligibility Criteria

Age6 Months - 35 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

This study was carried out at Hacettepe University, İhsan Doğramacı Children's Hospital, Department of Metabolism, between January 2020 and June 2020. It was planned to include patients who were followed up with the diagnosis of phenylketonuria with diet or Sapropterin hydrochloride therapy, who didn't have BH4 metabolism disorder or any other health problem. Pregnant patients were also excluded

You may qualify if:

  • Phenylketonuria patients

You may not qualify if:

  • BH4 metabolism disorde
  • Other chronic illness
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University

Ankara, Sihhiye, 06100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Psychological Well-BeingCaregiver BurdenStress, Psychological

Interventions

Psychological Tests

Condition Hierarchy (Ancestors)

Personal SatisfactionBehaviorBehavioral Symptoms

Intervention Hierarchy (Ancestors)

Behavioral Disciplines and Activities

Study Officials

  • Serap Sivri, Prof

    Hacettepe University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

February 10, 2024

First Posted

February 28, 2024

Study Start

May 27, 2020

Primary Completion

September 1, 2020

Study Completion

September 1, 2020

Last Updated

February 28, 2024

Record last verified: 2024-02

Locations